Identification of kinetin riboside as a repressor of CCND1 and CCND2 with preclinical antimyeloma activity
J. Clin. Invest. Rodger E. Tiedemann, et al. 118:1750
doi:10.1172/JCI34149 [Go to this article.]

Problems with a PDF?